Testing effectiveness (Phase 2)Looking for participantsNCT07024407
What this trial is testing
Andecaliximab in People With Spinal Cord Injury at Risk for Bone Growth Outside of the Normal Skeleton.
Who this might be right for
Heterotopic Ossification (HO)
Ashibio Inc 10